N
HCAT icon

Nuveen’s Health Catalyst HCAT Stock Holding History

Nuveen’s Portfolio HCAT Stock Details HCAT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$234K Buy
184,377
+60,725
+49% +$114K ﹤0.01% 3067
2025
Q4 		$296K Hold
123,652
– – ﹤0.01% 3049
2025
Q3 		$352K Hold
123,652
– – ﹤0.01% 3011
2025
Q2 		$466K Sell
123,652
-466,725
-79% -$1.84M ﹤0.01% 2907
2025
Q1 		$2.67M Sell
590,377
-3,266
-0.6% -$17.3K ﹤0.01% 2212
2024
Q4 		$4.2M Sell
593,643
-35,645
-6% -$284K ﹤0.01% 2062
2024
Q3 		$5.12M Buy
629,288
+1,103
+0.2% +$7.97K ﹤0.01% 1976
2024
Q2 		$4.01M Sell
628,185
-133,181
-17% -$855K ﹤0.01% 2060
2024
Q1 		$5.73M Sell
761,366
-11,362
-1% -$104K ﹤0.01% 1917
2023
Q4 		$7.16M Buy
772,728
+127,475
+20% +$1.04M ﹤0.01% 1779
2023
Q3 		$6.53M Buy
645,253
+94,339
+17% +$1.13M ﹤0.01% 1733
2023
Q2 		$6.89M Sell
550,914
-10,442
-2% -$124K ﹤0.01% 1737
2023
Q1 		$6.55M Sell
561,356
-25,824
-4% -$329K ﹤0.01% 1740
2022
Q4 		$6.24M Buy
587,180
+61,488
+12% +$594K ﹤0.01% 1789
2022
Q3 		$5.1M Buy
525,692
+13,264
+3% +$176K ﹤0.01% 1890
2022
Q2 		$7.42M Buy
512,428
+243,755
+91% +$4.16M ﹤0.01% 1701
2022
Q1 		$6.55M Buy
268,673
+6,783
+3% +$192K ﹤0.01% 1914
2021
Q4 		$9.58M Sell
261,890
-34,717
-12% -$1.58M ﹤0.01% 1723
2021
Q3 		$16.4M Sell
296,607
-124,752
-30% -$6.8M 0.01% 1413
2021
Q2 		$23.4M Sell
421,359
-22,165
-5% -$1.18M 0.01% 1242
2021
Q1 		$20.7M Sell
443,524
-117,102
-21% -$5.67M 0.01% 1293
2020
Q4 		$24.4M Buy
560,626
+31,191
+6% +$1.15M 0.01% 1124
2020
Q3 		$19.4M Buy
529,435
+263,179
+99% +$8.94M 0.01% 1079
2020
Q2 		$7.77M Buy
266,256
+121,554
+84% +$3.36M ﹤0.01% 1658
2020
Q1 		$3.78M Buy
144,702
+125,930
+671% +$3.85M ﹤0.01% 1872
2019
Q4 		$651K Sell
18,772
-2,373
-11% -$78.6K ﹤0.01% 2839
2019
Q3 		$669K Buy
+21,145
New +$832K ﹤0.01% 2851

Other funds holding HCAT

FLAM
First Light Asset Management Edina, Minnesota $1.12B AUM 114.45% 1-Year Est. Return
CF
CDC Financial Chicago, Illinois $157M AUM
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
WCA
Whetstone Capital Advisors Shawnee Mission, Kansas $288M AUM 44.06% 1-Year Est. Return
PVM
Palogic Value Management Dallas, Texas $237M AUM 5.37% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
Impax Asset Management Group
Impax Asset Management Group London, United Kingdom $14.3B AUM 19.8% 1-Year Est. Return
NI
Nepsis Inc Minneapolis, Minnesota $295M AUM 35.44% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Nuveen's HCAT Position: Q1 2026 in Review

Nuveen increased its Health Catalyst (HCAT) stake by 49% in Q1 2026, buying an estimated $114K and bringing the position to 184,377 shares worth $234K. The position accounts for ﹤0.01% of the portfolio, ranked #3067.

Nuveen first reported a position in HCAT in Q3 2019 and has held it in 27 quarters since. The position peaked at $24.4M in Q4 2020. 130 funds tracked by Wall St. Rank hold HCAT as of Q1 2026.

  • Nuveen held 184,377 shares of Health Catalyst worth $234K as of Q1 2026.
  • Nuveen bought 60,725 Health Catalyst shares in Q1 2026, an estimated $114K.
  • Health Catalyst made up ﹤0.01% of Nuveen's portfolio in Q1 2026, its #3067 holding.
  • Nuveen first reported a position in Health Catalyst in Q3 2019 and has held it in 27 quarters since.
  • Nuveen's Health Catalyst position peaked at $24.4M in Q4 2020.
  • 130 funds tracked by Wall St. Rank held Health Catalyst as of Q1 2026.

Based on Nuveen's 13F filing for Q1 2026, filed 30 Apr 2026.